Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention

Published:2018-12-01 Issue:12 Volume:25 Page:1255-1273
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Wang Yun¹,Ping Yen Yan Bryan²,Tomlinson Brian³,Bruce Nichol Michael⁴,Lee Vivian Wing Yan¹

Affiliation:

1. School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong

2. Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong

3. Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong

4. Sol Price School of Public Policy, Leonard D. Schaeffer Center for Health Policy and Economics, Department of Pharmaceutical and Health Economics, School of Pharmacy, University of Southern California

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/25/12/25_44818/_pdf

Reference49 articles.

1. 1) Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R and Baigent C: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (London, England), 2012; 380: 581-590

2. 2) Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R and Simes R: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (London, England), 2005; 366: 1267-1278

3. 3) Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J and Collins R: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (London, England), 2010; 376: 1670-1681

4. 4) Grundy S, Becker D, Clark L, Cooper R, Denke M, Howard J, Hunninghake D, Illingworth D, Luepker R and McBride P: The Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III or ATP III) guidelines for the management of serum lipids for high risk patients including those with a coronary artery disease equivalent[J]. Circulation, 2004; 109: 433-438

5. 5) Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC and Stone NJ: Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation, 2004; 110: 227-239

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence of the Impact of Programs to Prevent and Manage Heart Disease and Stroke;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

2. Evidence of the Impact of Programmes to Prevent and Manage Heart Disease and Stroke;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2022

3. Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention;Medicine;2020-08-14

4. Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome;Medical Science Monitor;2019-12-13